Anti-RANA antibody in rheumatoid arthritis, seronegative polyarthritis, and normal controls
- 16 Downloads
Anti-RANA antibody was found in 76% and 69% of seropositive and seronegative rheumatoid patients. No correlation appeared between this antibody, rheumatoid factor or a positive fluorescent anti-nuclear antibody (FANA). Many sera from healthy individuals, paritcularly medical personnel, and other disease groups demonstrated the fine nuclear speckling by immunofluorescence on Raji cells, but with weaker fluorescence. Anti-IgG conjugate was more sensitive in detecting the presence of the antibody in these sera. The presence of other antibodies producing a diffuse nuclear fluorescent pattern on Raji cells made it difficult to assess underlying fine nuclear speckling. Many of these sera produced a positive FANA on rat liver substrate. Very little variation in anti-RANA antibody status occurred with time and any change that did occur did so independently of rheumatoid factor. In view of the presence of anti-RANA antibody in the sera of patients with a variety of underlying rheumatic disorders and in normal individuals, the exact role of the antibody in the pathogenesis or diagnosis of rheumatoid arthritis is in doubt.
Key wordsAnti-RANA antibody Rheumatoid arthritis
Unable to display preview. Download preview PDF.
- 1.Alspaugh MA, Tan EM (1975) Antibodies to cellular antigens in sjogren's syndrome. J Clin Invest 55:1067–1073Google Scholar
- 2.Alspaugh MA, Talal N, Tan EM (1976) Differentiation and characterization of autoantibodies and their antigens in sjogren's syndrome. Arthritis Rheum 19:216–222Google Scholar
- 3.Alspaugh MA, Tan EM (1976) Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen-demonstration by precipitation and immunofluorescence. Arthritis Rheum 19:711–719Google Scholar
- 4.Alspaugh MA, Jensen FC, Rabin H, Tan EM (1978) Lymphocytes transformed by Epstein-Barr virus — induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 147:1018–1027Google Scholar
- 5.Vaughan JH (1979) Dunlop-Dottridge Lecture — rheumatoid arthritis, rheumatoid factor and the Epstein-Barr virus. J Rheumatol 6:381–387Google Scholar
- 6.Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH (1979) Antibodies to Epstein-Barr virus determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA 76:5825–5828Google Scholar
- 7.Ng KC, Brown KA, Perry JD, Holborow EJ (1980) Anti-RANA antibody — a marker for seronegative and seropositive rheumatoid arthritis. Lancet I:447–449Google Scholar
- 8.Catalano MA, Carson DA, Nuderman JC, Feorino P, Vaughan JH (1980) Antibody to the rheumatoid arthritis nuclear antigen — its relationship to in vivo Epstein-Barr virus infection. J Clin Invest 65:1238–1242Google Scholar
- 9.Catalano MA, Carson DA, Stastny P, Freer S, Vaughan JH (1980) Correlation between anti-RANA and anti-EBNA in normal subjects with and without HLA-DRw4. Arthritis Rheum 23:1049–1052Google Scholar
- 10.Bardwick PA, Bluestein HG, Zvaifler NJ, Depper JM, Seegmiller JE (1980) Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum 23:626–632Google Scholar